GTC Biotherapeutics (fka GTCB)

[vanmaarsum]

ATryn®, the First Recombinant Antithrombin; Innovation or Alternative?

GTC SYMPOSIUM AT XXIst ISTH CONGRESS



If you are attenting the XXIst Congress of the International Society on Thrombosis
and Haemostasis (ISTH), July 6 - 12, 2007 in Geneva, Switzerland, we invite you
to join the GTC Symposium in Room Salève on Wednesday, July 11, 2007 from
1:00PM - 2:00PM.


ATryn®, the First Recombinant Antithrombin; Innovation or Alternative?


ATryn®, An Alternative to Plasma Derived Antithrombin
Prof. Mario von Depka
Werlhof-Institute for Haemostasis and Thrombosis


The Transgenic Production System; An Emphasis on Safety & Purity
Dr. Harry Meade, Sr. Vice President
GTC Biotherapeutics, Inc.


http://www.atiii.com/ISTHSymposium.htm